NCT02376699 2023-05-01Safety Study of SEA-CD40 in Cancer PatientsSeagen Inc.Phase 1 Terminated159 enrolled
NCT03524898 2022-09-28NAPAGE: NAb-PAclitaxel and GEmcitabine in Advanced Soft Tissue SarcomaSwiss Cancer InstitutePhase 1/2 Terminated39 enrolled
NCT02241551 2018-07-26Phase II Neoadjuvant Chemotheraphy (Gemcitabine and Nab-Paclitaxel vs. mFOLFIRINOX) and Sterotatic Body Radiation Therapy for Borderline Resectable Pancreatic CancerUniversity of PittsburghPhase 2 Terminated2 enrolled 7 charts